Development and validation of a multivariable model predicting the required catheter dwell time among mechanically ventilated critically ill patients in three randomized trials.
Catheter dwell time
Central venous catheters
Critical care
Intensive care unit
Predictive score
Journal
Annals of intensive care
ISSN: 2110-5820
Titre abrégé: Ann Intensive Care
Pays: Germany
ID NLM: 101562873
Informations de publication
Date de publication:
16 Jan 2023
16 Jan 2023
Historique:
received:
19
10
2022
accepted:
03
01
2023
entrez:
16
1
2023
pubmed:
17
1
2023
medline:
17
1
2023
Statut:
epublish
Résumé
The anatomic site for central venous catheter insertion influences the risk of central venous catheter-related intravascular complications. We developed and validated a predictive score of required catheter dwell time to identify critically ill patients at higher risk of intravascular complications. We retrospectively conducted a cohort study from three multicenter randomized controlled trials enrolling consecutive patients requiring central venous catheterization. The primary outcome was the required catheter dwell time, defined as the period between the first catheter insertion and removal of the last catheter for absence of utility. Predictors were identified in the training cohort (3SITES trial; 2336 patients) through multivariable analyses based on the subdistribution hazard function accounting for death as a competing event. Internal validation was performed in the training cohort by 500 bootstraps to derive the CVC-IN score from robust risk factors. External validation of the CVC-IN score were performed in the testing cohort (CLEAN, and DRESSING2; 2371 patients). The analysis was restricted to patients requiring mechanical ventilation to comply with model assumptions. Immunosuppression (2 points), high creatinine > 100 micromol/L (2 points), use of vasopressor (1 point), obesity (1 point) and older age (40-59, 1 point; ≥ 60, 2 points) were independently associated with the required catheter dwell time. At day 28, area under the ROC curve for the CVC-IN score was 0.69, 95% confidence interval (CI) [0.66-0.72] in the training cohort and 0.64, 95% CI [0.61-0.66] in the testing cohort. Patients with a CVC-IN score ≥ 4 in the overall cohort had a median required catheter dwell time of 24 days (versus 11 days for CVC-IN score < 4 points). The positive predictive value of a CVC-IN score ≥ 4 was 76.9% for > 7 days required catheter dwell time in the testing cohort. The CVC-IN score, which can be used for the first catheter, had a modest ability to discriminate required catheter dwell time. Nevertheless, preference of the subclavian site may contribute to limit the risk of intravascular complications, in particular among ventilated patients with high CVC-IN score. Trials Registration NCT01479153, NCT01629550, NCT01189682.
Sections du résumé
BACKGROUND
BACKGROUND
The anatomic site for central venous catheter insertion influences the risk of central venous catheter-related intravascular complications. We developed and validated a predictive score of required catheter dwell time to identify critically ill patients at higher risk of intravascular complications.
METHODS
METHODS
We retrospectively conducted a cohort study from three multicenter randomized controlled trials enrolling consecutive patients requiring central venous catheterization. The primary outcome was the required catheter dwell time, defined as the period between the first catheter insertion and removal of the last catheter for absence of utility. Predictors were identified in the training cohort (3SITES trial; 2336 patients) through multivariable analyses based on the subdistribution hazard function accounting for death as a competing event. Internal validation was performed in the training cohort by 500 bootstraps to derive the CVC-IN score from robust risk factors. External validation of the CVC-IN score were performed in the testing cohort (CLEAN, and DRESSING2; 2371 patients).
RESULTS
RESULTS
The analysis was restricted to patients requiring mechanical ventilation to comply with model assumptions. Immunosuppression (2 points), high creatinine > 100 micromol/L (2 points), use of vasopressor (1 point), obesity (1 point) and older age (40-59, 1 point; ≥ 60, 2 points) were independently associated with the required catheter dwell time. At day 28, area under the ROC curve for the CVC-IN score was 0.69, 95% confidence interval (CI) [0.66-0.72] in the training cohort and 0.64, 95% CI [0.61-0.66] in the testing cohort. Patients with a CVC-IN score ≥ 4 in the overall cohort had a median required catheter dwell time of 24 days (versus 11 days for CVC-IN score < 4 points). The positive predictive value of a CVC-IN score ≥ 4 was 76.9% for > 7 days required catheter dwell time in the testing cohort.
CONCLUSION
CONCLUSIONS
The CVC-IN score, which can be used for the first catheter, had a modest ability to discriminate required catheter dwell time. Nevertheless, preference of the subclavian site may contribute to limit the risk of intravascular complications, in particular among ventilated patients with high CVC-IN score. Trials Registration NCT01479153, NCT01629550, NCT01189682.
Identifiants
pubmed: 36645531
doi: 10.1186/s13613-023-01099-9
pii: 10.1186/s13613-023-01099-9
pmc: PMC9842826
doi:
Banques de données
ClinicalTrials.gov
['NCT01479153', 'NCT01189682', 'NCT01629550', 'NCT01479153']
Types de publication
Journal Article
Langues
eng
Pagination
5Informations de copyright
© 2023. The Author(s).
Références
Adv Exp Med Biol. 2020;1196:11-18
pubmed: 32468303
Clin Obes. 2022 Aug;12(4):e12526
pubmed: 35429144
Cochrane Database Syst Rev. 2015 Jan 09;1:CD006962
pubmed: 25575244
Intensive Care Med. 2012 Oct;38(10):1662-72
pubmed: 22797354
Infect Control Hosp Epidemiol. 2022 May;43(5):553-569
pubmed: 35437133
Crit Care Med. 2020 May;48(5):623-633
pubmed: 32141923
Lancet. 2015 Nov 21;386(10008):2069-2077
pubmed: 26388532
BMC Microbiol. 2014 Jul 04;14:180
pubmed: 24996423
N Engl J Med. 2015 Sep 24;373(13):1220-9
pubmed: 26398070
BMC Med Res Methodol. 2011 Oct 26;11:144
pubmed: 22029846
Am J Respir Crit Care Med. 2012 Dec 15;186(12):1272-8
pubmed: 23043083
J Leukoc Biol. 2018 Feb;103(2):295-309
pubmed: 29345350
Front Pharmacol. 2015 Aug 13;6:171
pubmed: 26321956
Crit Care. 2006;10(6):R162
pubmed: 17112371
Intensive Care Med. 2016 Sep;42(9):1418-26
pubmed: 27311311
Crit Care. 2009;13(1):R15
pubmed: 19200368
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
Intensive Care Med. 2021 Apr;47(4):435-443
pubmed: 33521871
Crit Care Med. 2017 Jul;45(7):e734-e735
pubmed: 28622231
Crit Care Med. 2012 May;40(5):1627-34
pubmed: 22511140
Platelets. 2022 Aug 18;33(6):869-878
pubmed: 35068290
Hemodial Int. 2022 Jan;26(1):13-22
pubmed: 34318564
Crit Care. 2008;12(2):R44
pubmed: 18384672
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Crit Care Med. 2018 Dec;46(12):e1136-e1144
pubmed: 30247241
J Crit Care. 2015 Dec;30(6):1299-302
pubmed: 26371715
Ann Intern Med. 2015 Sep 15;163(6 Suppl):S1-40
pubmed: 26369828
Ann Intensive Care. 2016 Dec;6(1):76
pubmed: 27502195
Intensive Care Med. 2019 Jul;45(7):968-976
pubmed: 31143996
Crit Care. 2022 Jul 7;26(1):205
pubmed: 35799302
Stat Med. 2013 Aug 15;32(18):3089-101
pubmed: 23494745
Stat Med. 2016 Sep 30;35(22):4056-72
pubmed: 27197622